2015
DOI: 10.1016/j.cbi.2014.12.019
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase – Carbonyl reductase 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 63 publications
(74 reference statements)
0
13
0
Order By: Relevance
“…luteolin, apigenin, epigallocatechin gallate, curcumin) have shown a significant inhibitory effect on CBR1 in vitro (Arai et al, 2015, Carlquist et al, 2008Hintzpeter et al, 2015). Most of these studies have been aimed towards improving anthracycline therapy in cancer treatment (Forrest & Gonzalez, 2000;Olson et al, 1988Olson et al, , 2003.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…luteolin, apigenin, epigallocatechin gallate, curcumin) have shown a significant inhibitory effect on CBR1 in vitro (Arai et al, 2015, Carlquist et al, 2008Hintzpeter et al, 2015). Most of these studies have been aimed towards improving anthracycline therapy in cancer treatment (Forrest & Gonzalez, 2000;Olson et al, 1988Olson et al, , 2003.…”
Section: Discussionmentioning
confidence: 99%
“…The experiments revealed curcumin as a tight-binding CBR1 inhibitor with a low IC 50 value of 382 nM and Ki value of 223 nM with respect to 2,3hexanedione (Hintzpeter et al, 2015). Curcumin also acts as an inhibitor for other reductases belonging to the AKR superfamily.…”
Section: The Inhibition Of Cbr1 By Polyphenolsmentioning
confidence: 96%
“…CUR can give up the potential to enhance the therapeutic effectiveness of daunorubicin by preventing heart tissue damage through the inhibition of CBR1 mediated reduction of daunorubicin to daunorubicinol. The inhibition of CBR1 can increase the efficacy of daunorubicin in cancer tissue and simultaneously decrease its cardiotoxicity 53 . Metabolic profile of Rhizoma paridis saponins combined with the turmeric intervention in H22 hepatocarcinoma mice tumor growth was validated by histopathological examination.…”
Section: Biological Activities Of Curcuminoidsmentioning
confidence: 99%
“…Interestingly, the inhibitory potency of ebselen, and even more so that of ebselen diselenide, is comparable to that of curcumin, which is one of the more potent tight-binding inhibitors of human CBR1 (Hintzpeter et al, 2015). The inhibition pattern of ebselen as well as that of ebselen diselenide is noncompetitive (K i values of 5.586 6 0.254 and 3.782 6 0.189 mM, respectively), suggesting that the two compounds are capable of inhibiting NADPH-dependent reductases by binding equally well to the free enzyme or to the enzymesubstrate complex.…”
Section: Discussionmentioning
confidence: 97%
“…Because the evidence in this regard is still scarce and unsettled (Tanaka et al, 2005;Hintzpeter et al, 2015), we initially evaluated the effects on anthracycline reductive metabolism of a variety of compounds (metal chelators, radical scavengers, antioxidants, b-blockers, nitrone spin traps, and lipid-lowering drugs) employed as protective agents against anthracycline-induced cardiotoxicity. Among the compounds examined here, many failed to significantly inhibit anthracycline alcohol metabolite formation (see Table 1), thus confirming that their cardioprotective effects against anthracycline-induced cardiotoxicity should be ascribed to their antioxidant and/or antiapoptotic properties (Gianni et al, 2008;van Dalen et al, 2011;Octavia et al, 2012;Cardinale et al, 2013).…”
Section: Discussionmentioning
confidence: 99%